Study guide

Anterior and intermediate uveitis patterns

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Anterior and intermediate uveitis patterns

Key Takeaways Explain This Topic AI

JIA-associated inflammation can be asymptomatic and requires risk-based slit-lamp screening.

Fuchs heterochromia may be absent; cataract and glaucoma often determine visual outcome.

Mild anterior cells with marked pressure elevation suggest a hypertensive uveitis mechanism.

Pars planitis is a defined subset of intermediate uveitis after associated causes are excluded.

Last updated: October 2026

A quiet-looking eye can still contain damaging inflammation

Anterior uveitis predominantly involves the anterior chamber; intermediate uveitis predominantly involves the vitreous. The symptom pattern, laterality, course, pressure and associated systemic disease help distinguish causes. Painful acute unilateral attacks associated with HLA-B27 differ from the often asymptomatic chronic anterior inflammation of juvenile idiopathic arthritis (JIA). Absence of redness is not evidence that a child's eye is safe.

Record standardized cell and flare findings, vitreous inflammation, synechiae, lens changes, pressure and macular status. Examine the posterior segment even when the presenting complaint is anterior. Optical coherence tomography helps detect macular oedema that may explain reduced vision more than the visible anterior cells. Investigations should follow the phenotype and history rather than a universal panel of every antibody test.

JIA-associated uveitis

JIA can cause chronic anterior uveitis with few symptoms, particularly in risk groups defined by age, arthritis category, antinuclear antibodies and disease duration. Regular slit-lamp screening is necessary even when the joints are controlled. Screening frequency is risk-based and should follow the relevant paediatric pathway; an annual symptom questionnaire is not an adequate substitute.

Complications include posterior synechiae, band keratopathy, cataract, glaucoma, macular oedema and amblyopia. Topical corticosteroids are commonly used initially, with pressure and lens monitoring. Persistent steroid-dependent or severe inflammation may require systemic steroid-sparing therapy coordinated with paediatric rheumatology. Methotrexate and selected monoclonal anti-TNF agents have an established role. Adalimumab has a European paediatric noninfectious anterior-uveitis indication from age two in the specified treatment setting; use the actual product information rather than extrapolating adult doses to children.

Assess visual development and refractive error alongside inflammatory control. A child may need amblyopia treatment after the media clear. Surgery for cataract or glaucoma requires coordinated control of inflammation and realistic discussion of recurrence and complications. Do not repeatedly escalate drops while ignoring adherence, steroid toxicity and the need for systemic treatment.

Fuchs and hypertensive anterior inflammation

Fuchs uveitis syndrome often has chronic low-grade anterior inflammation, diffuse small stellate keratic precipitates, vitreous cells and iris stromal change. Heterochromia can be subtle or absent, especially with similar iris pigmentation. Posterior synechiae are generally absent. Cataract and glaucoma are important causes of visual loss. Routine prolonged topical steroid treatment for every mild stable case can add harm; manage complications and reassess atypical findings.

Posner–Schlossman syndrome describes recurrent mild anterior inflammation with disproportionate pressure elevation. Cytomegalovirus is implicated in a subset of hypertensive anterior uveitis, and aqueous testing may be useful in selected cases. Differentiate herpes-associated disease, steroid response and ordinary glaucoma. Treat the acute pressure and inflammation, and address a demonstrated viral cause when appropriate. Recurrent attacks can still damage the nerve despite their apparently mild inflammatory appearance.

  • Pattern Useful discriminators Major management concern
  • HLA-B27-associated Acute recurrent attacks, often symptomatic Inflammation and associated systemic disease

JIA-associated Chronic, potentially asymptomatic childhood disease Screening, complications and steroid-sparing care

Fuchs Diffuse stellate deposits, iris change, usually no synechiae Cataract and glaucoma

Hypertensive viral pattern High pressure, mild cells, characteristic iris or endothelial changes Viral assessment and pressure damage

Intermediate disease and pars planitis

Patients may report floaters and blurred vision with little pain. Vitreous cells, snowballs and inferior pars plana snowbanking support an intermediate pattern. Pars planitis is an intermediate uveitis with snowballs or snowbanks without an associated infection or systemic disease; it should not be used as a synonym for every intermediate uveitis.

Consider multiple sclerosis, sarcoidosis and infection according to the history and findings. Neurological symptoms or a relevant phenotype may justify MRI and neurological assessment. A positive unrelated screening test should not displace careful anatomical classification. Macular oedema, cataract, glaucoma, vitreous haemorrhage and tractional complications can affect vision.

Treatment intensity follows inflammatory activity and threat to vision. Observation may fit mild inactive disease without complications. Local or systemic corticosteroids, steroid-sparing therapy and selected surgery are used for more significant disease after infectious causes are addressed. When considering anti-TNF treatment, assess demyelinating disease risk and coordinate specialist decisions.

Directed case answer

A child with JIA and no ocular complaints still needs slit-lamp screening. An adult with a quiet-looking eye, pressure of 42 mmHg and mild anterior cells needs a hypertensive uveitis differential rather than reassurance. A patient with floaters, snowballs and macular oedema requires intermediate-uveitis assessment, including the distinction between pars planitis and disease associated with a systemic cause.

Sources: ACR JIA-uveitis guideline and EMA Humira information .

Sections you finish are checked off in the contents.

  • Up Next
  • HLA-B27, sarcoidosis, Behçet disease and VKH
  • Continue learning